2026 NDAA: China Biotech and Outbound Investment Provisions

Key Takeaways

• The NDAA includes key China-related provisions on biotechnology and outbound investments that had been considered in Congress for several years.
• The GAIN AI Act, which would have required domestic AI chipmakers to prioritize US buyers over foreign ones and imposed more restrictions on AI chip exports, was conspicuously left out of the legislation.
• USCBC provides key implementation deadlines and benchmarks for these bills and will offer opportunities for member companies to engage with experts on the NDAA provisions in 2026.